Rationale for use mefloquine for COVID-19 treatment
Currently, the use of mefloquine in patients with COVID-19 does not have sufficient scientific justification and, given the unfavorable efficacy and safety profile, cannot be considered for routine use in clinical practice.
2021 ◽
Vol 20
(3)
◽
pp. 185
Keyword(s):
Keyword(s):
2013 ◽
Vol 167
(6)
◽
pp. 2600-2604
◽
2012 ◽
Vol 157
(2)
◽
pp. 303-304
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. TPS156-TPS156
◽
Keyword(s):
Keyword(s):
Keyword(s):